Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01067976 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI
A Phase 3 study, sponsored by Bayer.
- Completed
- Registry status
- Phase 3
- Development phase
- 446
- Enrollment target
NCT01067976 is a Phase 3 study that has completed, run by Bayer. The registered enrollment target is 446 participants.
The verdict
NCT01067976, a Phase 3 study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 446 participants
- Enrollment target
Study Summary
The purpose of this study is to look at the efficacy (how does it work) and safety of gadobutrol when used for obtaining MR images of both breasts.Women with a recent diagnosis of breast cancer by mammogram (X-ray examination of the breasts) may benefit from MRI of the breasts as MRI may detect additional breast cancers.
Interventions
- DRUG Gadobutrol (Gadavist, Gadovist, BAY86-4875)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 446 participants |
| Start Date | 2010-02 |
| Est. Completion | 2012-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01067976
The ClinicalTrials.gov registry entry for NCT01067976 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 446 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gadobutrol (Gadavist, Gadovist, BAY86-4875) is the first listed.
NCT01067976 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01067976 about?
NCT01067976 is a clinical study titled "Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI". The purpose of this study is to look at the efficacy (how does it work) and safety of gadobutrol when used for obtaining MR images of both breasts.Women with a recent diagnosis of breast cancer by mammogram (X-ray examination of the breasts) may benefit from MRI of the breasts as MRI may detect addi...
What is the current status of trial NCT01067976?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 446 participants. The study started on 2010-02. Estimated completion is 2012-01.
What interventions are being tested in trial NCT01067976?
The interventions under investigation include: Gadobutrol (Gadavist, Gadovist, BAY86-4875) (DRUG).
Who is sponsoring clinical trial NCT01067976?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.